img

Global Pediatric Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pediatric Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pediatric Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pediatric Vaccines market is projected to reach US$ 45100 million in 2034, increasing from US$ 29730 million in 2022, with the CAGR of 5.7% during the period of 2024 to 2034. Demand from Newborn and Infant are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Pediatric Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Pediatric Vaccines key manufacturers include GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic and Baxter, etc. GlaxoSmithKline, Merck, Pfizer are top 3 players and held % sales share in total in 2022.
Pediatric Vaccines can be divided into Diphtheria, Influenza, Hepatitis and Pneumococcal Diseases, etc. Diphtheria is the mainstream product in the market, accounting for % sales share globally in 2022.
Pediatric Vaccines is widely used in various fields, such as Newborn, Infant, Child and Dolescent, etc. Newborn provides greatest supports to the Pediatric Vaccines industry development. In 2022, global % sales of Pediatric Vaccines went into Newborn filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pediatric Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


GlaxoSmithKline
Merck
Pfizer
Sanofi
AstraZeneca
Novartis
Takeda Pharmaceutical
Bavarian Nordic
Baxter
LG Life Sciences
Lupin
S K Chemicals
Mitsubishi Tanabe Pharma
Janssen
Shenzhen Kangtai Biological Products
Sinovac Biotech
Bharat Biotech
Crucell
Dynavax
Serum Institute of India
Segment by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Others

Segment by Application


Newborn
Infant
Child
Dolescent

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Pediatric Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pediatric Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pediatric Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pediatric Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pediatric Vaccines introduction, etc. Pediatric Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pediatric Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pediatric Vaccines Market Overview
1.1 Pediatric Vaccines Product Overview
1.2 Pediatric Vaccines Market Segment by Type
1.2.1 Diphtheria
1.2.2 Influenza
1.2.3 Hepatitis
1.2.4 Pneumococcal Diseases
1.2.5 Meningococcal Diseases
1.2.6 Others
1.3 Global Pediatric Vaccines Market Size by Type
1.3.1 Global Pediatric Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Pediatric Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pediatric Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pediatric Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pediatric Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pediatric Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Type (2018-2024)
2 Global Pediatric Vaccines Market Competition by Company
2.1 Global Top Players by Pediatric Vaccines Sales (2018-2024)
2.2 Global Top Players by Pediatric Vaccines Revenue (2018-2024)
2.3 Global Top Players by Pediatric Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Pediatric Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Pediatric Vaccines Market
2.8 Key Manufacturers Pediatric Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pediatric Vaccines Status and Outlook by Region
3.1 Global Pediatric Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pediatric Vaccines Historic Market Size by Region
3.2.1 Global Pediatric Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Pediatric Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Pediatric Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pediatric Vaccines Forecasted Market Size by Region
3.3.1 Global Pediatric Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Pediatric Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Pediatric Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pediatric Vaccines by Application
4.1 Pediatric Vaccines Market Segment by Application
4.1.1 Newborn
4.1.2 Infant
4.1.3 Child
4.1.4 Dolescent
4.2 Global Pediatric Vaccines Market Size by Application
4.2.1 Global Pediatric Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Pediatric Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pediatric Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pediatric Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pediatric Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pediatric Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pediatric Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pediatric Vaccines Sales Breakdown by Application (2018-2024)
5 North America Pediatric Vaccines by Country
5.1 North America Pediatric Vaccines Historic Market Size by Country
5.1.1 North America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pediatric Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Pediatric Vaccines Sales in Value by Country (2018-2024)
5.2 North America Pediatric Vaccines Forecasted Market Size by Country
5.2.1 North America Pediatric Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Pediatric Vaccines Sales in Value by Country (2024-2034)
6 Europe Pediatric Vaccines by Country
6.1 Europe Pediatric Vaccines Historic Market Size by Country
6.1.1 Europe Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pediatric Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Pediatric Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Pediatric Vaccines Forecasted Market Size by Country
6.2.1 Europe Pediatric Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Pediatric Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Pediatric Vaccines by Region
7.1 Asia-Pacific Pediatric Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Pediatric Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pediatric Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Pediatric Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pediatric Vaccines Sales in Value by Region (2024-2034)
8 Latin America Pediatric Vaccines by Country
8.1 Latin America Pediatric Vaccines Historic Market Size by Country
8.1.1 Latin America Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pediatric Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pediatric Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Pediatric Vaccines Forecasted Market Size by Country
8.2.1 Latin America Pediatric Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pediatric Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Pediatric Vaccines by Country
9.1 Middle East and Africa Pediatric Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Pediatric Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pediatric Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Pediatric Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pediatric Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Company Information
10.1.2 GlaxoSmithKline Introduction and Business Overview
10.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 GlaxoSmithKline Pediatric Vaccines Products Offered
10.1.5 GlaxoSmithKline Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merck Pediatric Vaccines Products Offered
10.2.5 Merck Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Introduction and Business Overview
10.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Pfizer Pediatric Vaccines Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Introduction and Business Overview
10.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sanofi Pediatric Vaccines Products Offered
10.4.5 Sanofi Recent Development
10.5 AstraZeneca
10.5.1 AstraZeneca Company Information
10.5.2 AstraZeneca Introduction and Business Overview
10.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 AstraZeneca Pediatric Vaccines Products Offered
10.5.5 AstraZeneca Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Novartis Pediatric Vaccines Products Offered
10.6.5 Novartis Recent Development
10.7 Takeda Pharmaceutical
10.7.1 Takeda Pharmaceutical Company Information
10.7.2 Takeda Pharmaceutical Introduction and Business Overview
10.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Takeda Pharmaceutical Pediatric Vaccines Products Offered
10.7.5 Takeda Pharmaceutical Recent Development
10.8 Bavarian Nordic
10.8.1 Bavarian Nordic Company Information
10.8.2 Bavarian Nordic Introduction and Business Overview
10.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Bavarian Nordic Pediatric Vaccines Products Offered
10.8.5 Bavarian Nordic Recent Development
10.9 Baxter
10.9.1 Baxter Company Information
10.9.2 Baxter Introduction and Business Overview
10.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Baxter Pediatric Vaccines Products Offered
10.9.5 Baxter Recent Development
10.10 LG Life Sciences
10.10.1 LG Life Sciences Company Information
10.10.2 LG Life Sciences Introduction and Business Overview
10.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 LG Life Sciences Pediatric Vaccines Products Offered
10.10.5 LG Life Sciences Recent Development
10.11 Lupin
10.11.1 Lupin Company Information
10.11.2 Lupin Introduction and Business Overview
10.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Lupin Pediatric Vaccines Products Offered
10.11.5 Lupin Recent Development
10.12 S K Chemicals
10.12.1 S K Chemicals Company Information
10.12.2 S K Chemicals Introduction and Business Overview
10.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 S K Chemicals Pediatric Vaccines Products Offered
10.12.5 S K Chemicals Recent Development
10.13 Mitsubishi Tanabe Pharma
10.13.1 Mitsubishi Tanabe Pharma Company Information
10.13.2 Mitsubishi Tanabe Pharma Introduction and Business Overview
10.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products Offered
10.13.5 Mitsubishi Tanabe Pharma Recent Development
10.14 Janssen
10.14.1 Janssen Company Information
10.14.2 Janssen Introduction and Business Overview
10.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Janssen Pediatric Vaccines Products Offered
10.14.5 Janssen Recent Development
10.15 Shenzhen Kangtai Biological Products
10.15.1 Shenzhen Kangtai Biological Products Company Information
10.15.2 Shenzhen Kangtai Biological Products Introduction and Business Overview
10.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products Offered
10.15.5 Shenzhen Kangtai Biological Products Recent Development
10.16 Sinovac Biotech
10.16.1 Sinovac Biotech Company Information
10.16.2 Sinovac Biotech Introduction and Business Overview
10.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Sinovac Biotech Pediatric Vaccines Products Offered
10.16.5 Sinovac Biotech Recent Development
10.17 Bharat Biotech
10.17.1 Bharat Biotech Company Information
10.17.2 Bharat Biotech Introduction and Business Overview
10.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Bharat Biotech Pediatric Vaccines Products Offered
10.17.5 Bharat Biotech Recent Development
10.18 Crucell
10.18.1 Crucell Company Information
10.18.2 Crucell Introduction and Business Overview
10.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Crucell Pediatric Vaccines Products Offered
10.18.5 Crucell Recent Development
10.19 Dynavax
10.19.1 Dynavax Company Information
10.19.2 Dynavax Introduction and Business Overview
10.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Dynavax Pediatric Vaccines Products Offered
10.19.5 Dynavax Recent Development
10.20 Serum Institute of India
10.20.1 Serum Institute of India Company Information
10.20.2 Serum Institute of India Introduction and Business Overview
10.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Serum Institute of India Pediatric Vaccines Products Offered
10.20.5 Serum Institute of India Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pediatric Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pediatric Vaccines Industrial Chain Analysis
11.4 Pediatric Vaccines Market Dynamics
11.4.1 Pediatric Vaccines Industry Trends
11.4.2 Pediatric Vaccines Market Drivers
11.4.3 Pediatric Vaccines Market Challenges
11.4.4 Pediatric Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pediatric Vaccines Distributors
12.3 Pediatric Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Diphtheria
Table 2. Major Company of Influenza
Table 3. Major Company of Hepatitis
Table 4. Major Company of Pneumococcal Diseases
Table 5. Major Company of Meningococcal Diseases
Table 6. Major Company of Others
Table 7. Global Pediatric Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Pediatric Vaccines Sales by Type (2018-2024) & (K Units)
Table 9. Global Pediatric Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 10. Global Pediatric Vaccines Sales by Type (2018-2024) & (US& Million)
Table 11. Global Pediatric Vaccines Market Share in Value by Type (2018-2024)
Table 12. Global Pediatric Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 13. Global Pediatric Vaccines Sales by Type (2024-2034) & (K Units)
Table 14. Global Pediatric Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 15. Global Pediatric Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 16. Global Pediatric Vaccines Sales Market Share in Value by Type (2024-2034)
Table 17. Global Pediatric Vaccines Price by Type (2024-2034) & (USD/Unit)
Table 18. North America Pediatric Vaccines Sales by Type (2018-2024) & (K Units)
Table 19. North America Pediatric Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Europe Pediatric Vaccines Sales (K Units) by Type (2018-2024)
Table 21. Europe Pediatric Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Asia-Pacific Pediatric Vaccines Sales (K Units) by Type (2018-2024)
Table 23. Asia-Pacific Pediatric Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Latin America Pediatric Vaccines Sales (K Units) by Type (2018-2024)
Table 25. Latin America Pediatric Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 26. Middle East and Africa Pediatric Vaccines Sales (K Units) by Type (2018-2024)
Table 27. Middle East and Africa Pediatric Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 28. Global Pediatric Vaccines Sales by Company (2018-2024) & (K Units)
Table 29. Global Pediatric Vaccines Sales Share by Company (2018-2024)
Table 30. Global Pediatric Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 31. Global Pediatric Vaccines Revenue Share by Company (2018-2024)
Table 32. Global Market Pediatric Vaccines Price by Company (2018-2024) & (USD/Unit)
Table 33. Global Pediatric Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 34. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 35. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2022)
Table 36. Date of Key Manufacturers Enter into Pediatric Vaccines Market
Table 37. Key Manufacturers Pediatric Vaccines Product Type
Table 38. Mergers & Acquisitions, Expansion Plans
Table 39. Global Pediatric Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 40. Global Pediatric Vaccines Sales by Region (2018-2024) & (K Units)
Table 41. Global Pediatric Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 42. Global Pediatric Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 43. Global Pediatric Vaccines Sales Market Share in Value by Region (2018-2024)
Table 44. Global Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 45. Global Pediatric Vaccines Sales by Region (2024-2034) & (K Units)
Table 46. Global Pediatric Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 47. Global Pediatric Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 48. Global Pediatric Vaccines Sales Market Share in Value by Region (2024-2034)
Table 49. Global Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 50. Global Pediatric Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 51. Global Pediatric Vaccines Sales by Application (2018-2024) & (K Units)
Table 52. Global Pediatric Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 53. Global Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 54. Global Pediatric Vaccines Sales Market Share in Value by Application (2018-2024)
Table 55. Global Pediatric Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 56. Global Pediatric Vaccines Sales by Application (2024-2034) & (K Units)
Table 57. Global Pediatric Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 58. Global Pediatric Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 59. Global Pediatric Vaccines Sales Market Share in Value by Application (2024-2034)
Table 60. Global Pediatric Vaccines Price by Application (2024-2034) & (USD/Unit)
Table 61. North America Pediatric Vaccines Sales by Application (2018-2024) (K Units)
Table 62. North America Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Europe Pediatric Vaccines Sales by Application (2018-2024) (K Units)
Table 64. Europe Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Asia-Pacific Pediatric Vaccines Sales by Application (2018-2024) (K Units)
Table 66. Asia-Pacific Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. Latin America Pediatric Vaccines Sales by Application (2018-2024) (K Units)
Table 68. Latin America Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 69. Middle East and Africa Pediatric Vaccines Sales by Application (2018-2024) (K Units)
Table 70. Middle East and Africa Pediatric Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 71. North America Pediatric Vaccines Sales by Country (2018-2024) & (K Units)
Table 72. North America Pediatric Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 73. North America Pediatric Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 74. North America Pediatric Vaccines Sales Market Share in Value by Country (2018-2024)
Table 75. North America Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 76. North America Pediatric Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 77. North America Pediatric Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 78. North America Pediatric Vaccines Sales Market Share in Value by Country (2024-2034)
Table 79. Europe Pediatric Vaccines Sales by Country (2018-2024) & (K Units)
Table 80. Europe Pediatric Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 81. Europe Pediatric Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 82. Europe Pediatric Vaccines Sales Market Share in Value by Country (2018-2024)
Table 83. Europe Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 84. Europe Pediatric Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 85. Europe Pediatric Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 86. Europe Pediatric Vaccines Sales Market Share in Value by Country (2024-2034)
Table 87. Asia-Pacific Pediatric Vaccines Sales by Region (2018-2024) & (K Units)
Table 88. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 89. Asia-Pacific Pediatric Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 90. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Region (2018-2024)
Table 91. Asia-Pacific Pediatric Vaccines Sales by Region (2024-2034) & (K Units)
Table 92. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 93. Asia-Pacific Pediatric Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 94. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Region (2024-2034)
Table 95. Latin America Pediatric Vaccines Sales by Country (2018-2024) & (K Units)
Table 96. Latin America Pediatric Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 97. Latin America Pediatric Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 98. Latin America Pediatric Vaccines Sales Market Share in Value by Country (2018-2024)
Table 99. Latin America Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 100. Latin America Pediatric Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 101. Latin America Pediatric Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 102. Latin America Pediatric Vaccines Sales Market Share in Value by Country (2024-2034)
Table 103. Middle East and Africa Pediatric Vaccines Sales by Country (2018-2024) & (K Units)
Table 104. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 105. Middle East and Africa Pediatric Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 106. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Country (2018-2024)
Table 107. Middle East and Africa Pediatric Vaccines Sales by Country (2024-2034) & (K Units)
Table 108. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 109. Middle East and Africa Pediatric Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 110. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Country (2024-2034)
Table 111. GlaxoSmithKline Company Information
Table 112. GlaxoSmithKline Introduction and Business Overview
Table 113. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 114. GlaxoSmithKline Pediatric Vaccines Product
Table 115. GlaxoSmithKline Recent Development
Table 116. Merck Company Information
Table 117. Merck Introduction and Business Overview
Table 118. Merck Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 119. Merck Pediatric Vaccines Product
Table 120. Merck Recent Development
Table 121. Pfizer Company Information
Table 122. Pfizer Introduction and Business Overview
Table 123. Pfizer Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 124. Pfizer Pediatric Vaccines Product
Table 125. Pfizer Recent Development
Table 126. Sanofi Company Information
Table 127. Sanofi Introduction and Business Overview
Table 128. Sanofi Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 129. Sanofi Pediatric Vaccines Product
Table 130. Sanofi Recent Development
Table 131. AstraZeneca Company Information
Table 132. AstraZeneca Introduction and Business Overview
Table 133. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 134. AstraZeneca Pediatric Vaccines Product
Table 135. AstraZeneca Recent Development
Table 136. Novartis Company Information
Table 137. Novartis Introduction and Business Overview
Table 138. Novartis Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 139. Novartis Pediatric Vaccines Product
Table 140. Novartis Recent Development
Table 141. Takeda Pharmaceutical Company Information
Table 142. Takeda Pharmaceutical Introduction and Business Overview
Table 143. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 144. Takeda Pharmaceutical Pediatric Vaccines Product
Table 145. Takeda Pharmaceutical Recent Development
Table 146. Bavarian Nordic Company Information
Table 147. Bavarian Nordic Introduction and Business Overview
Table 148. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 149. Bavarian Nordic Pediatric Vaccines Product
Table 150. Bavarian Nordic Recent Development
Table 151. Baxter Company Information
Table 152. Baxter Introduction and Business Overview
Table 153. Baxter Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 154. Baxter Pediatric Vaccines Product
Table 155. Baxter Recent Development
Table 156. LG Life Sciences Company Information
Table 157. LG Life Sciences Introduction and Business Overview
Table 158. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 159. LG Life Sciences Pediatric Vaccines Product
Table 160. LG Life Sciences Recent Development
Table 161. Lupin Company Information
Table 162. Lupin Introduction and Business Overview
Table 163. Lupin Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 164. Lupin Pediatric Vaccines Product
Table 165. Lupin Recent Development
Table 166. S K Chemicals Company Information
Table 167. S K Chemicals Introduction and Business Overview
Table 168. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 169. S K Chemicals Pediatric Vaccines Product
Table 170. S K Chemicals Recent Development
Table 171. Mitsubishi Tanabe Pharma Company Information
Table 172. Mitsubishi Tanabe Pharma Introduction and Business Overview
Table 173. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 174. Mitsubishi Tanabe Pharma Pediatric Vaccines Product
Table 175. Mitsubishi Tanabe Pharma Recent Development
Table 176. Janssen Company Information
Table 177. Janssen Introduction and Business Overview
Table 178. Janssen Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 179. Janssen Pediatric Vaccines Product
Table 180. Janssen Recent Development
Table 181. Shenzhen Kangtai Biological Products Company Information
Table 182. Shenzhen Kangtai Biological Products Introduction and Business Overview
Table 183. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 184. Shenzhen Kangtai Biological Products Pediatric Vaccines Product
Table 185. Shenzhen Kangtai Biological Products Recent Development
Table 186. Sinovac Biotech Company Information
Table 187. Sinovac Biotech Introduction and Business Overview
Table 188. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 189. Sinovac Biotech Pediatric Vaccines Product
Table 190. Sinovac Biotech Recent Development
Table 191. Bharat Biotech Company Information
Table 192. Bharat Biotech Introduction and Business Overview
Table 193. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 194. Bharat Biotech Pediatric Vaccines Product
Table 195. Bharat Biotech Recent Development
Table 196. Crucell Company Information
Table 197. Crucell Introduction and Business Overview
Table 198. Crucell Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 199. Crucell Pediatric Vaccines Product
Table 200. Crucell Recent Development
Table 201. Dynavax Company Information
Table 202. Dynavax Introduction and Business Overview
Table 203. Dynavax Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 204. Dynavax Pediatric Vaccines Product
Table 205. Dynavax Recent Development
Table 206. Serum Institute of India Company Information
Table 207. Serum Institute of India Introduction and Business Overview
Table 208. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 209. Serum Institute of India Pediatric Vaccines Product
Table 210. Serum Institute of India Recent Development
Table 211. Key Raw Materials Lists
Table 212. Raw Materials Key Suppliers Lists
Table 213. Pediatric Vaccines Market Trends
Table 214. Pediatric Vaccines Market Drivers
Table 215. Pediatric Vaccines Market Challenges
Table 216. Pediatric Vaccines Market Restraints
Table 217. Pediatric Vaccines Distributors List
Table 218. Pediatric Vaccines Downstream Customers
Table 219. Research Programs/Design for This Report
Table 220. Key Data Information from Secondary Sources
Table 221. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Vaccines Product Picture
Figure 2. Global Pediatric Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pediatric Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pediatric Vaccines Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Diphtheria
Figure 6. Global Diphtheria Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Influenza
Figure 8. Global Influenza Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Hepatitis
Figure 10. Global Hepatitis Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Pneumococcal Diseases
Figure 12. Global Pneumococcal Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Meningococcal Diseases
Figure 14. Global Meningococcal Diseases Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Product Picture of Others
Figure 16. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 17. Global Pediatric Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 18. Global Pediatric Vaccines Sales Market Share by Type in 2022 & 2034
Figure 19. North America Pediatric Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. North America Pediatric Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Europe Pediatric Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Europe Pediatric Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Type in 2022
Figure 25. Latin America Pediatric Vaccines Sales Market Share in Volume by Type in 2022
Figure 26. Latin America Pediatric Vaccines Sales Market Share in Value by Type in 2022
Figure 27. Middle East and Africa Pediatric Vaccines Sales Market Share in Volume by Type in 2022
Figure 28. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Type in 2022
Figure 29. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Sales in 2022
Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Vaccines Revenue in 2022
Figure 31. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Product Picture of Newborn
Figure 33. Global Newborn Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Infant
Figure 35. Global Infant Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Child
Figure 37. Global Child Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Product Picture of Dolescent
Figure 39. Global Dolescent Sales YoY Growth (2018-2034) & (K Units)
Figure 40. Global Pediatric Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Pediatric Vaccines Sales Market Share by Application in 2022 & 2034
Figure 42. North America Pediatric Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. North America Pediatric Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Europe Pediatric Vaccines Sales Market Share in Volume by Application in 2022
Figure 45. Europe Pediatric Vaccines Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Pediatric Vaccines Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Pediatric Vaccines Sales Market Share in Value by Application in 2022
Figure 48. Latin America Pediatric Vaccines Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Pediatric Vaccines Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Pediatric Vaccines Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Pediatric Vaccines Manufacturing Cost Structure
Figure 53. Pediatric Vaccines Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed